Home LiteratureArticle Details
PMID: 106013 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Passive immunization against Pseudomonas with a ribosomal vaccine-induced immune serum and immunoglobulin fractions.

Infection and immunity ·Vol. 23 ·No. 2 ·1979-02-00 ·Pages 509-21

Lieberman MM, McKissock DC, Wright GL

Abstract

Passive protection of mice against Pseudomonas aeruginosa using specific antisera and immunoglobulin fractions induced by immunizing rabbits with a ribosomal vaccine is reported. The results demonstrated that protection by the ribosomal vaccine against challenge with live organisms can be serum mediated. Previous work has shown that the vaccine can be separated into two components on the basis of molecular weight and that both higher (peak A)- and lower (peak B)-molecular-weight fractions were capable of inducing active immunity in mice. The present report indicates that both fractions are also capable of eliciting the production of mouse-protective antibody in rabbits. Agar gel diffusion with antisera to peaks A and B or unfractionated vaccine indicated a common antigenic component among them in addition to an extra antigen in unfractionated vaccine not present in peak B. Passive hemagglutination with antisera to peaks A and B demonstrated high-titer agglutinating antibody only with antiserum to peak A when a method of erythrocyte sensitization for lipopolysaccharide antigens was used. Also, passive hemagglutination was greatly inhibited by small amounts of lipopolysaccharide prepared from the same organism from which the vaccine was made. Both antisera to peaks A and B fixed complement with either A or B antigens. Antisera to peaks A and B, when reacted with peak B antigen, had about the same complement fixation titer (as determined by a quantitative complement fixation test). However, when peak A antigen was used, antiserum to peak A had about twice the complement fixation titer that antiserum to peak B had. These results are consistent with previous observations which suggest that the ribosomal vaccine contains lipopolysaccharide in addition to an unidentified immunogenic principle associated with ribosomes. Furthermore, this immunogen was present in both peaks A and B, but detectable amounts of lipopolysaccharide were present only in peak A. The relative importance of the immunoglobulin G (IgG) and IgM classes of antibodies was also compared. The results indicated that both IgG and IgM isolated from immune rabbit serum are protective in mice. Only IgG precipitated with the vaccine in agar gel diffusion, but both IgG and IgM were active in passive hemagglutination and in complement fixation. The passive hemagglutination titer of the IgM was higher than that of the IgG, but the complement fixation titer of the IgG was higher than that of the IgM. The mouse-protective capability of the IgG and IgM was about the same.

MeSH Terms
Animals Antibodies, Bacterial/biosynthesis,immunology Bacterial Vaccines Female Immunity, Maternally-Acquired Immunoglobulin G/immunology Immunoglobulin M/immunology Immunoglobulins/immunology Male Mercaptoethanol/pharmacology Mice Pseudomonas Infections/immunology Pseudomonas aeruginosa/immunology Rabbits Ribosomes/immunology
Chemicals
Antibodies, Bacterial Bacterial Vaccines Immunoglobulin G Immunoglobulin M Immunoglobulins Mercaptoethanol
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lieberman M M
McKissock D C
Wright G L
References (42)
42 references, click to expand
  1. Biological properties of an immunogenic pneumococcal subcellular preparation.
    Infect Immun. 1976 Mar;13(3):750-7 PMID: 5373
  2. Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.
    Infect Immun. 1976 Aug;14(2):345-54 PMID: 9362
  3. Cross-protective immunity to Gram-negative bacilli: studies with core glycolipid of Salmonella minnesota and antigens of Streptococcus pneumoniae.
    J Infect Dis. 1977 Aug;136 Suppl:S174-80 PMID: 19538
  4. Immuno-stimulation by a ribosomal vaccine associated with a bacterial cell wall adjuvant in humans.
    Infect Immun. 1978 Jun;20(3):760-9 PMID: 27461
  5. Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella.
    Infect Immun. 1975 Aug;12(2):364-77 PMID: 51007
  6. Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli.
    J Infect Dis. 1976 Jan;133(1):37-45 PMID: 54397
  7. A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection.
    J Infect Dis. 1977 Aug;136 Suppl:S181-5 PMID: 70492
  8. Antigenic relationship between the common antigen (OEP) of Pseudomonas aeruginosa and Vibrio cholerae.
    Infect Immun. 1978 Feb;19(2):373-7 PMID: 75846
  9. Immunogenic capacity of ribosomes of Salmonella typhi interfered with a flagellin-like material contaminant.
    Infect Immun. 1978 Apr;20(1):161-6 PMID: 97221
  10. Pseudomonas ribosomal vaccines: preparation, properties, and immunogenicity.
    Infect Immun. 1978 Jul;21(1):76-86 PMID: 101464
  11. Biochemical and immunological properties of ribonucleic acid-rich extracts from Francisella tularensis.
    Infect Immun. 1975 Jul;12(1):137-42 PMID: 237834
  12. Immunoprotective activity of ribosomes from Haemophilus influenzae.
    Infect Immun. 1977 Feb;15(2):453-60 PMID: 300360
  13. Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae.
    Infect Immun. 1978 Jan;19(1):58-65 PMID: 304844
  14. Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.
    J Infect Dis. 1977 Aug;136 Suppl:S161-6 PMID: 330775
  15. Antibody to cell wall glycolipid of Gram-negative bacteria: induction of immunity to bacteremia and endotoxemia.
    J Infect Dis. 1977 Aug;136 Suppl:S167-73 PMID: 330776
  16. Direct evidence for the presence of lipopolysaccharide components in Pseudomonas ribosomal vaccine.
    Infect Immun. 1977 Aug;17(2):471-3 PMID: 408275
  17. Glycolipoprotein from Pseudomonas aeruginosa as a protective antigen against P. aeruginosa infection in mice.
    Infect Immun. 1977 Nov;18(2):304-9 PMID: 411754
  18. Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2.
    Infect Immun. 1978 Jan;19(1):29-33 PMID: 415004
  19. Role of exotoxin and protease as possible virulence factors in experimental infections with Pseudomonas aeruginosa.
    Infect Immun. 1978 Mar;19(3):839-45 PMID: 417031
  20. Evidence for an extrinsic immunogen in effective ribosomal vaccines from Salmonella typhimurium.
    Infect Immun. 1976 Apr;13(4):1184-92 PMID: 776831
  21. Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.
    Infect Immun. 1975 Jun;11(6):1195-202 PMID: 806521
  22. Immunogenic activity of a ribosomal fraction obtained from Pasteurella multocida.
    Infect Immun. 1977 Jan;15(1):1-6 PMID: 832895
  23. Immunization against Pseudomonas in infection after thermal injury.
    J Infect Dis. 1974 Nov;130 Suppl(0):S152-8 PMID: 4138646
  24. Ribosomal vaccines. II. Specificity of the immune response to ribosomal ribonucleic acid and protein isolated from Salmonella typhimurium.
    Infect Immun. 1973 Sep;8(3):395-400 PMID: 4199718
  25. Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A.
    J Infect Dis. 1973 Oct;128(4):520-6 PMID: 4200593
  26. Efficacy of ribosomal preparations from Pseudomonas aeruginosa to protect against intravenous Pseudomonas challenge in mice.
    J Reticuloendothel Soc. 1974 Jan;15(1):22-30 PMID: 4204145
  27. Ribosomal vaccines. I. Immunogenicity of ribosomal fractions isolated from Salmonella typhimurium and Yersinia pestis.
    Infect Immun. 1972 Jun;5(6):947-52 PMID: 4564407
  28. Purification of immunogenically active ribonucleic acid preparations of Salmonella typhimurium: molecular-sieve and anion-exchange chromatography.
    Infect Immun. 1972 Mar;5(3):269-82 PMID: 4564556
  29. Immunity to Salmonella typhimurium infection: characterization of antigens in active protection by polyacrylamide gel electrophoresis.
    Infect Immun. 1973 Mar;7(3):507-11 PMID: 4576683
  30. Type-specific immunity in pseudomonas diseases.
    J Lab Clin Med. 1972 Jan;79(1):47-54 PMID: 4621414
  31. Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.
    J Infect Dis. 1972 Sep;126(3):257-76 PMID: 4626509
  32. Passive protective properties of serum fractions from mice inoculated with an anti-pseudomonas vaccine.
    Immunology. 1972 Dec;23(6):889-95 PMID: 4630781
  33. Serum-mediated resistance induced with immunogenic preparations of Salmonella typhimurium.
    Infect Immun. 1971 Oct;4(4):374-80 PMID: 4949497
  34. Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate.
    J Bacteriol. 1966 Jun;91(6):2139-45 PMID: 4957609
  35. Immunization against Pseudomonas aeruginosa. I. Induction of protection by an alcohol-precipitated fraction from the slime layer.
    J Infect Dis. 1967 Jun;117(3):249-56 PMID: 4961397
  36. Immunity induced by ribosomal extracts from Staphylococcus aureus.
    J Reticuloendothel Soc. 1970 Jul;8(1):66-73 PMID: 5432870
  37. Quantitative micro-complement fixation test.
    Appl Microbiol. 1971 Feb;21(2):260-4 PMID: 5544287
  38. Dissociation of human serum macroglobulins.
    Science. 1957 Mar 29;125(3248):600-1 PMID: 13409017
  39. A colorimetric method for the determination of sugars.
    Nature. 1951 Jul 28;168(4265):167 PMID: 14875032
  40. Biological Activities of Rabbit Immunoglobulin M and Immunoglobulin G Antibodies to Pseudomonas aeruginosa.
    Infect Immun. 1970 Oct;2(4):453-61 PMID: 16557861
  41. Immunogenic mycobacterial ribosomal and ribonucleic Acid preparations: chemical and physical characteristics.
    Infect Immun. 1970 Nov;2(5):659-68 PMID: 16557892
  42. Passive immunization against experimental pseudomonas infection: correlation of protection to verder and evans "o" serotypes.
    Infect Immun. 1971 Jan;3(1):51-8 PMID: 16557946
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1979-02-00
Pages
509-21
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC414194
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]